Singh / Tripathi Protein-based Therapeutics

1. Auflage 2023
ISBN: 978-981-19-8249-1
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 384 Seiten, eBook

This book provides an overview of the essential characteristics and clinical applications of therapeutic proteins against human diseases, including cancers, immune disorders, infections, and other diseases. It presents the latest advancements in protein engineering techniques for producing desirable therapeutic proteins. The book also covers the strategies used to formulate and deliver systemic therapeutic proteins, approved protein therapeutics and their targets, and pharmacogenetic biomarkers. Further, it discusses challenges associated with the clinical implications of therapeutic proteins, including safety, immunogenicity, protein stability, degradation, and efficacy. It illustrates the development of biosimilar antibodies, optimization strategies for producing biobetter antibodies, and presents fundamental concepts about biosuperior therapeutics. Lastly, it includes a discussion about protein-based vaccines against bacterial and viral infections.

Zielgruppe

Research

Autoren/Hrsg.

Singh, Dev Bukhsh

Tripathi, Timir

Inhaltsverzeichnis

Chapter 1_ Introduction to Protein Therapeutics ..- Chapter 2_ Clinical Applications of Protein-based Therapeutics Against Various Diseases. .- Chapter 3_ Protein Engineering Methods for the Design of Protein Therapeutics .- Chapter 4_ Recombinant Production of Therapeutic Proteins .- Chapter 5_ Antibodies as Protein Therapeutics .- Chapter 6_ Streptokinase: The Success Story of a Therapeutic Protein .- Chapter 7_ Strategies for Formulation and Systemic Delivery of Therapeutic Proteins .- Chapter 8_ Approved Protein Therapeutics and Their Biochemical Targets .- Chapter 9_ Pharmacogenetic Biomarkers of Protein Therapeutics .- Chapter 10_ Immunogenicity of Therapeutic Proteins .- Chapter 11_ Efficacy and Safety Issues of Therapeutic Proteins .- Chapter 12_ Emerging Trends, Challenges, and Opportunities in Protein Therapeutics .- Chapter 13_ Biosimilar, Biobetter & Biosuperior Therapeutic Proteins .- Chapter 14_ Therapeutic Protein-based Vaccines.

Über Autor(innen)

Dev Bukhsh Singh  is an Assistant Professor at the Department of Biotechnology, Siddharth University, Kapilvastu, Siddharth Nagar, India. He also worked as an Assistant Professor at the Department of Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur, India. He received his B.Sc. and M.Sc. degrees from the University of Allahabad, Prayagraj, and his M.Tech. from the Indian Institute of Information Technology, Prayagraj. Holding a PhD in Biotechnology with a specialization in Bioinformatics from Gautam Buddha University, he has been actively involved in teaching and research since 2009, and his focus areas include molecular modelling, chemoinformatics, inhibitor/drug design, and in silico evaluation. He has authored numerous research articles and book chapters in the fields of medicinal research, molecular modelling, drug design, and systems biology. He is a member of various national and international academic bodies and is a reviewer for several internationaljournals. Timir Tripathi is the Regional Director of Indira Gandhi National Open University (IGNOU), Regional Centre Kohima, Nagaland, India. Earlier, he served as Senior Assistant Professor and Principal Investigator at the Department of Biochemistry, North-Eastern Hill University, Shillong, India. He holds a PhD from the Central Drug Research Institute, Lucknow, India. He was a visiting faculty at ICGEB, New Delhi, India (2011), and Khon Kaen University, Thailand (2015). He is known for his research in the fields of protein biophysics, biochemistry, structural biology, and drug discovery. He has over 17 years of experience in teaching and research on protein structure, function, and dynamics at the post-graduate and doctoral levels. He has developed and improved methods to investigate and analyze proteins. His research areas include protein interaction dynamics and understanding the roles of non-catalytic domains in regulating the catalytic activity of proteins. He has published over 100 research papers, reviews, commentaries, viewpoints, and editorial articles; has edited four books; and published several book chapters. He currently serves on the editorial boards of the International Journal of Biological Macromolecules, Acta Tropica, Scientific Reports, and PLoS One.